SM

Syringomyelia, commonly abbreviated as SM, is a serious neurological condition in dogs characterized by the development of fluid-filled cavities, known as syrinxes, within the substance of the spinal cord. These cavities form when the normal circulation of cerebrospinal fluid (CSF) is disrupted, causing fluid to be forced into the spinal cord parenchyma under pressure. The condition is most frequently associated with Chiari-like malformation (CM), a skull and brain conformational abnormality that obstructs CSF flow at the junction between the skull and the cervical spine.

The relationship between CM and SM has been extensively studied, particularly in the Cavalier King Charles Spaniel, a breed in which the prevalence of the condition is alarmingly high. In CM, the caudal portion of the brain, specifically the cerebellum and brainstem, is crowded within a skull that is disproportionately small relative to the brain volume. This overcrowding obstructs the foramen magnum, the opening at the base of the skull through which the spinal cord exits, and disrupts the pulsatile flow of CSF between the cranial and spinal compartments.

SM can range from an incidental imaging finding with no associated clinical signs to a severely debilitating condition causing chronic pain, neurological deficits, and significant reduction in quality of life. The spectrum of disease severity is broad, and the clinical presentation does not always correlate directly with the size or extent of the syrinx visible on imaging. Some dogs with large syrinxes remain minimally symptomatic, while others with relatively small cavities experience significant pain and dysfunction.

The condition has gained increasing attention in veterinary neurology and the breeding community over the past two decades, driven by growing awareness of its high prevalence in certain breeds, advances in MRI diagnostics, and the development of screening programs aimed at reducing the incidence through informed breeding practices.

The pathophysiology of syringomyelia in dogs is intimately linked to the dynamics of cerebrospinal fluid circulation and the structural abnormalities that disrupt it. Under normal conditions, CSF is produced by the choroid plexus within the brain's ventricles, circulates through the ventricular system and subarachnoid space, and is absorbed through various pathways. This circulation follows a pulsatile pattern synchronized with the cardiac cycle, with CSF flowing caudally during systole and rostrally during diastole.

In dogs with Chiari-like malformation, the herniation of cerebellar tissue through the foramen magnum creates a physical obstruction to the normal pulsatile flow of CSF at the craniocervical junction. This obstruction generates abnormal pressure differentials between the cranial and spinal CSF compartments with each heartbeat. The repeated pulsatile pressure waves are transmitted into the spinal cord tissue, gradually forcing CSF into the central canal and parenchyma of the cord, leading to the formation and progressive enlargement of syrinx cavities.

The syrinx typically develops in the cervical region of the spinal cord, corresponding to the area closest to the CSF flow obstruction, though it may extend caudally into the thoracic and occasionally the lumbar spinal cord. The expanding fluid cavity damages the neural tissue surrounding it through a combination of direct mechanical compression, demyelination of nerve fibers, and disruption of local blood supply. The dorsal horn of the spinal cord, which processes sensory information including pain and temperature, is often particularly affected, accounting for many of the characteristic clinical signs.

Secondary factors that may influence syrinx formation and progression include arachnoid adhesions that further obstruct CSF flow, spinal cord tethering, and venous drainage abnormalities within the spinal canal. Research has also suggested that the relative size of the caudal fossa, the bony compartment housing the cerebellum, varies among individual dogs and breeds, with smaller fossa volumes predisposing to greater cerebellar crowding and more significant CSF flow obstruction.

The progressive nature of syringomyelia means that syrinx cavities tend to enlarge over time in many affected dogs, though the rate of progression varies considerably. Some dogs show rapid expansion of the syrinx with escalating clinical signs, while others remain relatively stable for extended periods. The factors that determine the rate of progression are not fully understood and remain an active area of research.

The clinical signs of syringomyelia in dogs reflect the location and extent of spinal cord damage caused by the expanding syrinx cavity. Symptoms can range from subtle behavioral changes to severe neurological dysfunction, and their progression may be gradual or episodic. Recognizing the characteristic clinical presentation is essential for early diagnosis and timely intervention.

Pain is the most prominent and consistent clinical sign in dogs with symptomatic SM. The pain is believed to originate from damage to the dorsal horn sensory pathways and may manifest as neck pain, shoulder pain, or a more diffuse discomfort that is difficult for owners to localize. Affected dogs may cry out spontaneously, particularly during transitions from rest to activity, when picked up, or when excited. Some dogs adopt abnormal postures to minimize discomfort, holding the head in an elevated position or resisting neck flexion. The pain often appears to be neuropathic in character, meaning it arises from nervous system dysfunction rather than tissue damage, which has important implications for treatment selection.

Phantom scratching is one of the most characteristic and recognizable signs of SM in dogs. This behavior involves the dog repeatedly lifting a hind leg toward the neck or shoulder area and making scratching motions without actually making contact with the skin. The scratching is triggered by abnormal sensory processing in the damaged dorsal horn and is analogous to the phantom sensations experienced by human patients with spinal cord lesions. The behavior is often triggered by excitement, walking on a leash with neck pressure, or changes in barometric pressure.

Sensory deficits may develop as the syrinx expands and damages sensory pathways. Affected dogs may show altered responses to touch or temperature stimuli along the neck, shoulders, and forelimbs. Some dogs develop facial sensitivity or ear sensitivity, rubbing their faces or ears frequently. In more advanced cases, proprioceptive deficits become apparent, with the dog showing uncoordinated or clumsy movements, particularly in the forelimbs.

Progressive neurological deterioration occurs in severely affected dogs as the expanding syrinx causes increasing destruction of spinal cord tissue. Weakness affecting one or more limbs, muscle wasting particularly in the forelimb and shoulder muscles, and scoliosis or abnormal spinal curvature may develop. In the most severe cases, dogs may become significantly disabled, though complete paralysis is uncommon. The rate and extent of progression vary greatly among individual dogs.

Magnetic resonance imaging (MRI) is the definitive diagnostic tool for syringomyelia, providing detailed visualization of the spinal cord, the syrinx cavities within it, and any associated craniocervical junction abnormalities. No other imaging modality provides comparable information about the soft tissue structures involved in this condition, making MRI essential for both diagnosis and treatment planning.

MRI examination of dogs suspected of having SM should include sagittal and transverse images of the entire cervical and cranial thoracic spinal cord, as well as images of the brain, particularly the caudal fossa region. The syrinx appears as a hyperintense fluid signal within the substance of the spinal cord on T2-weighted images. The size, location, and extent of the syrinx are carefully documented, including its maximum transverse diameter relative to the spinal cord diameter, its length measured in vertebral body segments, and whether it is symmetrical or asymmetrical within the cord.

The MRI evaluation also characterizes the degree of Chiari-like malformation present. The extent of cerebellar herniation through the foramen magnum is measured, and the degree of CSF flow obstruction at the craniocervical junction is assessed. Cine-phase contrast MRI, a specialized technique that measures CSF flow velocities, can provide additional functional information about the degree of CSF flow disturbance, though this technique is not available at all veterinary MRI centers.

Grading systems have been developed to standardize the reporting of SM severity on MRI. These systems typically classify dogs based on the presence or absence of a syrinx, the maximum diameter of the syrinx, and whether the central canal is dilated without forming a true syrinx. A widely used classification distinguishes between dogs with no syrinx (SM0), dogs with central canal dilation only (SM1), and dogs with a syrinx measuring two millimeters or more in diameter (SM2). These grades are used in breeding screening programs to guide selection decisions.

Clinical correlation is essential when interpreting MRI findings, as the relationship between syrinx size and clinical severity is imperfect. Some dogs with large syrinxes on MRI remain clinically unaffected, while others with smaller cavities exhibit significant symptoms. Repeat MRI examinations over time may be performed to monitor syrinx progression and to assess the response to treatment, particularly following surgical intervention.

Medical management of syringomyelia focuses primarily on controlling pain and reducing CSF production, as no medication can directly resolve the structural abnormalities responsible for syrinx formation. The neuropathic nature of SM-associated pain means that conventional analgesics alone are often insufficient, and multimodal pain management strategies incorporating drugs that target neuropathic pain pathways are typically required.

Gabapentin is considered a first-line medication for SM-associated pain in dogs. This anticonvulsant drug modulates calcium channel activity in the central nervous system and reduces the abnormal neuronal firing that generates neuropathic pain signals. Gabapentin is generally well tolerated in dogs, with sedation being the most common side effect, particularly at the initiation of therapy or after dose increases. Pregabalin, a related drug with higher bioavailability and more predictable pharmacokinetics, is used as an alternative in dogs that do not respond adequately to gabapentin.

Nonsteroidal anti-inflammatory drugs (NSAIDs) may provide additional analgesic benefit, particularly in dogs with concurrent musculoskeletal pain or inflammatory components to their discomfort. These medications should be used cautiously in conjunction with other drugs and require periodic monitoring of renal and hepatic function. Corticosteroids, while effective at reducing CSF production and decreasing inflammation and edema around the syrinx, carry significant long-term side effects including polyuria, polydipsia, weight gain, and immunosuppression. Short courses or pulse therapy may be used during acute exacerbations, but long-term daily corticosteroid use is generally avoided.

Omeprazole, a proton pump inhibitor primarily used for gastrointestinal conditions, has been incorporated into SM treatment protocols based on evidence that it may reduce CSF production. By inhibiting carbonic anhydrase activity in the choroid plexus, omeprazole may decrease the volume of CSF produced and thereby reduce the hydrostatic forces driving syrinx formation and expansion. Cimetidine, another acid-reducing medication, has also been used for this purpose.

Adjunctive therapies including acupuncture, physical rehabilitation, and environmental modifications can complement pharmacological management. Avoiding pressure on the neck from collars is strongly recommended, with harnesses being substituted for all leash activities. Weight management reduces mechanical stress on the spine. Temperature and weather changes that exacerbate symptoms should be anticipated and managed with preemptive medication adjustments when possible.

Surgical intervention for syringomyelia is considered when medical management fails to adequately control clinical signs or when the condition is rapidly progressive. The primary surgical goal is to restore normal CSF flow at the craniocervical junction, thereby reducing the abnormal pressure dynamics that drive syrinx formation and expansion. Several surgical approaches have been described, each with specific indications, advantages, and limitations.

Foramen magnum decompression surgery, also known as suboccipital craniectomy or cranial cervical decompression, is the most commonly performed procedure for CM/SM in dogs. This surgery involves removing a portion of the occipital bone at the base of the skull and often the dorsal arch of the first cervical vertebra to enlarge the foramen magnum and create more space for CSF flow around the cervicomedullary junction. The procedure aims to eliminate the obstruction that drives syrinx formation without directly intervening on the spinal cord itself.

Duraplasty, in which the dura mater overlying the decompression site is opened and patched with a graft material to create additional space, is frequently performed in conjunction with foramen magnum decompression. The graft material may be autologous tissue such as fascia or fat, or synthetic materials specifically designed for dural reconstruction. The addition of duraplasty may improve CSF flow dynamics more effectively than bony decompression alone.

Syrinx shunting procedures, in which a tube is placed directly into the syrinx cavity to drain the accumulated fluid into the subarachnoid space or another body cavity, have been performed but carry higher complication rates and are less commonly recommended as primary procedures. The small diameter of the shunt tubes makes them prone to obstruction, and the procedure carries risks of additional spinal cord damage during insertion.

Surgical outcomes are variable, and owners should be counseled that surgery aims to halt progression and alleviate pain rather than to cure the condition. Studies report clinical improvement in approximately 80 percent of dogs following foramen magnum decompression, though some dogs experience recurrence of signs over months to years as scar tissue formation at the surgical site recreates the CSF flow obstruction. Revision surgery may be necessary in a subset of cases. The best surgical outcomes are generally achieved in younger dogs with shorter duration of clinical signs prior to surgery.

Postoperative management includes strict rest during the recovery period, continuation of analgesic medications with gradual weaning as clinical signs improve, and periodic reassessment including follow-up MRI to monitor the response to surgery. Complications may include seroma formation, wound infection, worsening of neurological signs, and anesthetic risks. Selection of an experienced veterinary neurosurgeon is essential for optimizing outcomes.

Syringomyelia is overwhelmingly associated with specific breeds, most notably the Cavalier King Charles Spaniel (CKCS), in which the condition has reached endemic proportions. Research has demonstrated that the vast majority of CKCS dogs have some degree of Chiari-like malformation, and a substantial proportion develop syringomyelia visible on MRI. Prevalence estimates for MRI-documented SM in CKCS populations range from approximately 25 percent in young dogs to over 70 percent in dogs over six years of age, though not all of these dogs develop clinical signs.

The extremely high prevalence of CM/SM in the CKCS is attributed to the breed's skull conformation, which has been shaped by decades of selective breeding for specific aesthetic traits including a domed skull, shortened muzzle, and large eyes. These desired physical characteristics are associated with a caudal fossa that is disproportionately small relative to the brain volume it must contain, creating the structural conditions for cerebellar herniation and CSF flow obstruction. The genetic basis for CM/SM in the CKCS is complex and polygenic, meaning it is influenced by multiple genes rather than a single mutation.

Brussels Griffons represent the second most commonly affected breed, with prevalence rates of CM/SM that rival those seen in CKCS. The brachycephalic skull conformation of the Brussels Griffon creates similar craniocervical junction crowding, and the condition is recognized as a significant health concern in the breed. King Charles Spaniels, the breed from which the Cavalier was derived, are also affected.

Other toy and small brachycephalic breeds have been reported with CM/SM, including Affenpinschers, Chihuahuas, Yorkshire Terriers, Maltese, Pomeranians, and Papillons. The condition has also been documented sporadically in larger breeds, including the Staffordshire Bull Terrier and the French Bulldog, suggesting that the underlying mechanisms are not exclusive to toy breeds. However, the prevalence in these breeds is substantially lower than in the CKCS and Brussels Griffon.

The high heritability of the condition in affected breeds raises important ethical questions about breeding practices and breed standards. Breed clubs, kennel clubs, and veterinary organizations have responded with varying degrees of urgency, with some implementing mandatory or recommended MRI screening programs and others advocating for modifications to breed standards that would select for skull conformations less likely to produce craniocervical junction crowding.

Recognizing the hereditary nature and high prevalence of CM/SM in susceptible breeds, veterinary organizations and breed clubs have developed screening programs aimed at reducing the incidence of the condition through informed breeding decisions. These programs rely primarily on MRI evaluation of breeding stock, combined with standardized grading systems and breeding guidelines.

The British Veterinary Association and the Kennel Club in the United Kingdom jointly sponsor a CM/SM screening scheme for Cavalier King Charles Spaniels and Brussels Griffons. Under this program, dogs intended for breeding undergo MRI examination of the brain and cervical spinal cord, and the images are evaluated by a designated panel of veterinary neurologists who assign standardized CM and SM grades. These grades are then used to guide breeding recommendations, with the general principle that dogs with lower grades should be preferred for breeding and that mating of two severely affected dogs should be avoided.

The recommended minimum age for screening MRI is typically one year for initial assessment, though later rescanning at three to five years of age is advised because SM can develop and progress with age. A dog that scans clear at one year may develop a visible syrinx by three or five years, so early screening provides only a snapshot of the dog's status at that point in time. This age-related progression complicates screening protocols and underscores the importance of rescanning.

Breeding guidelines generally recommend mating only dogs with the lowest available SM grades and avoiding the mating of two dogs with significant syrinxes. The guidelines recognize that completely excluding all dogs with any degree of CM/SM from breeding would unacceptably narrow the gene pool in breeds where prevalence is extremely high, and they therefore adopt a pragmatic approach aimed at gradual improvement over generations rather than immediate elimination of the condition.

Challenges facing screening programs include the cost of MRI examinations, which can be prohibitive for some breeders, the limited availability of MRI facilities in certain regions, the incomplete penetrance and variable expressivity of the condition, and resistance from segments of the breeding community who are reluctant to accept the scope of the problem. Education and outreach efforts targeting breeders, owners, and the general public are essential for the success of these programs.

Genetic research aimed at identifying specific markers or genes associated with CM/SM susceptibility continues, with the ultimate goal of developing DNA-based tests that could complement or eventually replace MRI-based screening. Such tests would be less expensive, more accessible, and could be performed at any age, overcoming several of the limitations of current screening approaches.

Managing daily life with a dog diagnosed with syringomyelia requires ongoing attention to the dog's comfort, careful environmental management, and a collaborative relationship with the veterinary neurology team. While the diagnosis can be emotionally difficult for owners, many dogs with SM live fulfilling lives with appropriate care and management.

The single most important daily management change for dogs with SM is the elimination of neck collars in favor of body harnesses for all walking and leash activities. Pressure on the neck from collars can exacerbate pain and worsen CSF flow dynamics at the craniocervical junction. A well-fitted, padded harness that distributes pressure across the chest and shoulders allows the dog to be walked comfortably without placing stress on the cervical region. This simple change alone can produce noticeable improvement in comfort for many affected dogs.

Monitoring and documenting the dog's clinical signs on a regular basis provides valuable information for the veterinary team and helps identify trends in disease progression or response to therapy. Owners should track the frequency and severity of pain episodes, phantom scratching behavior, activity levels, appetite, and any new neurological signs. A simple diary or log can be invaluable during veterinary consultations and helps guide medication adjustments.

Environmental modifications that reduce neck flexion and strain can enhance comfort. Elevated food and water bowls minimize the need for the dog to lower its head to eat and drink. Ramp access to furniture and vehicles eliminates the jarring impact of jumping. Soft, supportive bedding provides comfort during rest periods. Some owners find that maintaining a consistent indoor temperature and avoiding sudden exposure to cold weather reduces symptom flare-ups, as weather changes are a recognized trigger for increased pain and phantom scratching in many affected dogs.

Emotional support for the owner is an often-overlooked aspect of managing SM. The chronic nature of the condition, the potential for progressive deterioration, and the financial demands of ongoing treatment can create significant stress. Support groups for owners of dogs with CM/SM exist online and can provide practical advice, emotional validation, and a sense of community. Open communication with the veterinary team about financial constraints, quality-of-life concerns, and treatment goals helps ensure that the management plan is both medically appropriate and sustainable for the family.

Regular veterinary follow-up appointments allow for medication adjustments, monitoring of side effects, and reassessment of the dog's neurological status. The frequency of follow-up depends on the severity of the condition and the stability of the dog's clinical signs, but visits every three to six months are generally recommended for dogs on active treatment.

Research into syringomyelia and Chiari-like malformation in dogs has expanded considerably over the past two decades, driven by the recognition of the condition's high prevalence in popular breeds and the desire to improve both treatment and prevention. The dog serves not only as a patient requiring veterinary care but also as a valuable naturally occurring model for human Chiari malformation and syringomyelia, creating opportunities for translational research that benefits both species.

Genetic research represents one of the most active and promising areas of SM investigation. Genome-wide association studies in Cavalier King Charles Spaniels and other affected breeds have identified chromosomal regions associated with CM/SM susceptibility, though the specific causative genes have not yet been definitively identified. The complex, polygenic nature of the condition makes genetic dissection challenging, but advances in whole-genome sequencing and large collaborative studies involving multiple research institutions are accelerating progress.

Advanced imaging techniques are providing new insights into the pathophysiology of SM. Computational fluid dynamics modeling, applied to MRI-derived anatomical data, allows researchers to simulate CSF flow patterns and pressure distributions at the craniocervical junction with unprecedented detail. These models are helping to explain why some dogs with CM develop SM while others do not, and they may ultimately guide surgical planning by predicting which dogs are most likely to benefit from decompression surgery.

Novel therapeutic approaches are being explored for both medical and surgical management. Research into targeted drug delivery systems that could deliver analgesic or neuroprotective agents directly to the affected spinal cord regions is ongoing. Advances in surgical materials, including biocompatible implants that resist scar tissue formation, may improve the durability of surgical outcomes and reduce the rate of recurrence following foramen magnum decompression.

Collaborative international research networks have been established to coordinate data collection, standardize diagnostic criteria, and share findings across institutions and countries. These networks facilitate large-scale studies that would not be feasible at individual centers and promote the rapid dissemination of new knowledge to clinicians managing affected dogs. The combined efforts of veterinary neurologists, geneticists, biomechanical engineers, and breed organizations continue to advance the understanding and management of this important condition.

Public awareness campaigns and breed health initiatives are also contributing to progress by increasing owner and breeder engagement with screening programs, supporting research funding, and advocating for breed standard modifications that prioritize health over extreme physical characteristics. The growing recognition that breed-related health conditions like SM represent both an animal welfare concern and a responsibility of the breeding community is driving meaningful change in breeding practices within several affected breeds.